The data from mouse experiments and clinical samples evaluation in the current study suggested Gal-1 had great potential to be a biomarker for discovering BMSCs senescence, diagnosing early osteoporosis and monitoring disease progression. This evidence concerns the gene LGALS1 and osteoporosis.